Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Noble

Showing results (61-70 of 405) with videos related to

Pageof 41
Sort By:
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 1, 1997
Cyclosporin: a review of its pharmacology and clinical potential in the treatment of systemic lupus erythematosusS Noble, A J Wagstaff
Genome Biology|September 3, 2015
Analysis methods for studying the 3D architecture of the genomeFerhat Ay, William S Noble
Journal of Virology|October 6, 1997
Core protein mu2 is a second determinant of nucleoside triphosphatase activities by reovirus coresS Noble, M L Nibert
Drugs|April 8, 1998
Tiagabine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the management of epilepsyJ C Adkins, S Noble
Molecular & Cellular Proteomics : MCP|November 19, 2025
Proteomics Data Imputation With a Deep Model That Learns From Many DatasetsLincoln Harris, William S Noble
Drugs|January 8, 1999
EfavirenzJ C Adkins, S Noble
Drugs|April 3, 1999
Aprotinin: an update of its pharmacology and therapeutic use in open heart surgery and coronary artery bypass surgeryD C Peters, S Noble
Drugs|April 8, 1999
Eptifibatide: a review of its use in patients with acute coronary syndromes and/or undergoing percutaneous coronary interventionK L Goa, S Noble
European Journal of Clinical Nutrition|February 1, 1994
Control of longitudinal growth: the role of nutritionN Loveridge, B S Noble
Virology|June 20, 1995
Characterization of putative defective interfering (DI) A/WSN RNAs isolated from the lungs of mice protected from an otherwise lethal respiratory infection with influenza virus A/WSN (H1N1): a subset of the inoculum DI RNAsS Noble, N J Dimmock
Pageof 41

Showing results (61-70 of 405) with videos related to

Sort By:
Pageof 41
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 1, 1997
Cyclosporin: a review of its pharmacology and clinical potential in the treatment of systemic lupus erythematosusS Noble, A J Wagstaff
Genome Biology|September 3, 2015
Analysis methods for studying the 3D architecture of the genomeFerhat Ay, William S Noble
Journal of Virology|October 6, 1997
Core protein mu2 is a second determinant of nucleoside triphosphatase activities by reovirus coresS Noble, M L Nibert
Drugs|April 8, 1998
Tiagabine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the management of epilepsyJ C Adkins, S Noble
Molecular & Cellular Proteomics : MCP|November 19, 2025
Proteomics Data Imputation With a Deep Model That Learns From Many DatasetsLincoln Harris, William S Noble
Drugs|January 8, 1999
EfavirenzJ C Adkins, S Noble
Drugs|April 3, 1999
Aprotinin: an update of its pharmacology and therapeutic use in open heart surgery and coronary artery bypass surgeryD C Peters, S Noble
Drugs|April 8, 1999
Eptifibatide: a review of its use in patients with acute coronary syndromes and/or undergoing percutaneous coronary interventionK L Goa, S Noble
European Journal of Clinical Nutrition|February 1, 1994
Control of longitudinal growth: the role of nutritionN Loveridge, B S Noble
Virology|June 20, 1995
Characterization of putative defective interfering (DI) A/WSN RNAs isolated from the lungs of mice protected from an otherwise lethal respiratory infection with influenza virus A/WSN (H1N1): a subset of the inoculum DI RNAsS Noble, N J Dimmock
Pageof 41